Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

757 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preclinical evaluation of a novel polyphosphazene surface modified stent.
Koppara T, Sakakura K, Pacheco E, Cheng Q, Zhao X, Acampado E, Finn AV, Barakat M, Maillard L, Ren J, Deshpande M, Kolodgie FD, Joner M, Virmani R. Koppara T, et al. Among authors: barakat m. Int J Cardiol. 2016 Nov 1;222:217-225. doi: 10.1016/j.ijcard.2016.07.181. Epub 2016 Jul 30. Int J Cardiol. 2016. PMID: 27497098
Effects of Simulated COVID-19 Cytokine Storm on Stent Thrombogenicity.
Cornelissen A, Kutyna M, Cheng Q, Sato Y, Kawakami R, Sakamoto A, Kawai K, Mori M, Fernandez R, Guo L, Pellegrini D, Guagliumi G, Barakat M, Virmani R, Finn A. Cornelissen A, et al. Among authors: barakat m. Cardiovasc Revasc Med. 2022 Feb;35:129-138. doi: 10.1016/j.carrev.2021.03.023. Epub 2021 Apr 8. Cardiovasc Revasc Med. 2022. PMID: 33863660 Free PMC article.
Five-Year Clinical Outcomes of the COBRA Polyzene F NanoCoated Coronary Stent System.
Cutlip DE, Jauhar R, Meraj P, Garratt KN, Novack V, Novack L, Maillard L, Erglis A, Stoler R, Barakat M, Silber S; PzF SHIELD Trial Investigators. Cutlip DE, et al. Among authors: barakat m. Cardiovasc Revasc Med. 2022 Aug;41:76-80. doi: 10.1016/j.carrev.2021.12.030. Epub 2022 Jan 3. Cardiovasc Revasc Med. 2022. PMID: 35045942 Clinical Trial.
Design and Rationale of a Randomized Trial of COBRA PzF Stenting to REDUCE Duration of Triple Therapy (COBRA-REDUCE).
Colleran R, Joner M, Cutlip D, Urban P, Maeng M, Jauhar R, Barakat M, Michel JM, Mehran R, Kirtane AJ, Maillard L, Kastrati A, Byrne RA; COBRA-REDUCE investigators. Colleran R, et al. Among authors: barakat m. Cardiovasc Revasc Med. 2022 Jan;34:17-24. doi: 10.1016/j.carrev.2021.01.022. Epub 2021 Jan 22. Cardiovasc Revasc Med. 2022. PMID: 33608239 Free article. Clinical Trial.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Wykoff CC, Abreu F, Adamis AP, Basu K, Eichenbaum DA, Haskova Z, Lin H, Loewenstein A, Mohan S, Pearce IA, Sakamoto T, Schlottmann PG, Silverman D, Sun JK, Wells JA, Willis JR, Tadayoni R; YOSEMITE and RHINE Investigators. Wykoff CC, et al. Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24. Lancet. 2022. PMID: 35085503 Clinical Trial.
Safety and Feasibility of Chemoembolization with Doxorubicin-Loaded Small Calibrated Microspheres in Patients with Hepatocellular Carcinoma: Results of the MIRACLE I Prospective Multicenter Study.
Richter G, Radeleff B, Stroszczynski C, Pereira P, Helmberger T, Barakat M, Huppert P. Richter G, et al. Among authors: barakat m. Cardiovasc Intervent Radiol. 2018 Apr;41(4):587-593. doi: 10.1007/s00270-017-1839-2. Epub 2017 Nov 22. Cardiovasc Intervent Radiol. 2018. PMID: 29167967 Free PMC article.
757 results